Sign in

CIK 0001347178

  • Accelerated filer

Vanda Pharmaceuticals Inc.

Sign in to watch
Ticker
VNDA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
030491827
Phone
+1 202-734-3400
Business address
2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, 20037
Open-market buys, last 90 days
$38,094
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$38,094. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Duncan Charles Cliff +$38K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-02-26 Williams Timothy SVP & General Counsel Grant or award · Employee Stock Option (Right to Buy) +70,000 70,000
2020-02-26 Wijkstrom Joakim SVP, Chief Marketing Officer Grant or award +30,000 60,000
2020-02-26 Wijkstrom Joakim SVP, Chief Marketing Officer Grant or award · Employee Stock Option (Right to Buy) +70,000 70,000
2020-02-26 Polymeropoulos Mihael Hristos President and CEO Grant or award +60,000 1,294,579
2020-02-26 Polymeropoulos Mihael Hristos President and CEO Grant or award · Employee Stock Option (Right to Buy) +140,000 140,000
2020-02-26 Jones Aranthan II Chief Corp. Affairs Officer Grant or award +30,000 90,000
2020-02-26 Jones Aranthan II Chief Corp. Affairs Officer Grant or award · Employee Stock Option (Right to Buy) +70,000 70,000
2020-02-26 Birznieks Gunther SVP, Business Development Grant or award +30,000 177,231
2020-02-26 Birznieks Gunther SVP, Business Development Grant or award · Employee Stock Option (Right to Buy) +70,000 70,000
2020-02-14 Mitchell Stephen Ray Director Grant or award · Stock Option (right to buy) +35,000 35,000
2020-01-02 Reverberi Gian Piero SVP & Chief Commercial Officer Sale −1,155 $16.06 $19K 166,834
2020-01-02 Polymeropoulos Mihael Hristos President and CEO Sale −9,467 $16.00 $151K 1,234,579
2020-01-02 Kelly James Patrick EVP & Chief Financial Officer Sale −4,020 $15.94 $64K 205,726
2020-01-02 Birznieks Gunther SVP, Business Development Sale −4,020 $15.93 $64K 147,231
2019-12-12 Polymeropoulos Mihael Hristos President and CEO Option exercise +85,801 $10.65 $914K 1,314,082
2019-12-12 Polymeropoulos Mihael Hristos President and CEO Sale −70,036 $16.98 $1.2M 1,244,046
2019-12-12 Polymeropoulos Mihael Hristos President and CEO Option exercise · Employee Stock Option (Right to Buy) −85,801 0
2019-12-11 Polymeropoulos Mihael Hristos President and CEO Option exercise +89,199 $10.65 $950K 1,300,654
2019-12-11 Polymeropoulos Mihael Hristos President and CEO Sale −72,373 $16.92 $1.2M 1,228,281
2019-12-11 Polymeropoulos Mihael Hristos President and CEO Option exercise · Employee Stock Option (Right to Buy) −89,199 85,801

Page 15 of 20 · 387 trades